Crossmark

Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from Singapore

Published Online: 2022-05-14

Published Print: 2023-10

Authors

Soh, Xin Qin https://orcid.org/0000-0003-2575-4530
Tan, Doreen Su-Yin https://orcid.org/0000-0002-2090-2517
Chan, Eric Chun Yong https://orcid.org/0000-0001-6107-9072
License Information

Text and Data Mining valid from 2022-05-14

Version of Record valid from 2022-05-14
More Information

Article History

Accepted: 4 May 2022

First Online: 14 May 2022

Declarations

:

: Ethics approval was obtained from the Domain Specific Review Board (Study reference number: 2017/00815). Informed consent by participants was obtained prior to data collection.

: The authors declare no competing interests.

Document is current